Advanced Nuclease Applications in Lentiviral Vector Bioprocessing for Superior Downstream Recovery and Vector Product Quality
TetraVecta™ Packaging Cell Lines for LV-CAR Production
Interim results presentation for the six months ended 30 June 2024
23 September 2024
Interim results for the six months ended 30 June 2024
23 September 2024
Novel Dual-Plasmid Transfection System Improves Titer And Product Quality In AAV Manufacturing
Innovative Platforms For Improved Viral Vector Development And Scale-Up
Enhancing Titres of Therapeutic Viral Vectors using the Transgene Repression in Vector Production TRiP System
Advancing Gene Therapy Development with a Multi Type AAV Affinity Resin
Achieving rAAV Bioreactor Titer of 1E15 vgL With Novel Plasmid Transient Transfection Platform
Podcast: Achieving Better AAV Productivity
LV: TetraVecta™ System Brochure
Interim results for the six months ended in 30 June 2024
23 September 2024
